| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,582 |
3,746 |
$393K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,833 |
1,572 |
$202K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,843 |
1,748 |
$147K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
239 |
235 |
$47K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
341 |
298 |
$42K |
| 80053 |
Comprehensive metabolic panel |
3,817 |
3,308 |
$36K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
706 |
674 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,623 |
3,117 |
$17K |
| 70450 |
Computed tomography, head or brain; without contrast material |
271 |
241 |
$14K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
170 |
167 |
$12K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
345 |
317 |
$11K |
| 80050 |
General health panel |
186 |
186 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
742 |
430 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
830 |
734 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
479 |
465 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
116 |
109 |
$8K |
| T1015 |
Clinic visit/encounter, all-inclusive |
232 |
64 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,049 |
867 |
$7K |
| 83880 |
|
297 |
267 |
$6K |
| 84484 |
|
983 |
697 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
143 |
143 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
346 |
319 |
$5K |
| 80061 |
Lipid panel |
352 |
350 |
$5K |
| 87040 |
|
411 |
260 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
201 |
177 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
26 |
26 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
41 |
41 |
$3K |
| 83690 |
|
733 |
642 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
139 |
137 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
2,223 |
1,536 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
51 |
51 |
$2K |
| 83605 |
|
636 |
488 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
392 |
360 |
$2K |
| 85610 |
|
847 |
624 |
$2K |
| 85730 |
|
480 |
415 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
412 |
403 |
$2K |
| 84703 |
|
192 |
183 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
809 |
731 |
$2K |
| 73564 |
|
90 |
87 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
388 |
328 |
$2K |
| 82150 |
|
409 |
367 |
$2K |
| 85378 |
|
196 |
189 |
$1K |
| 81003 |
|
596 |
539 |
$1K |
| 83735 |
|
251 |
233 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
90 |
79 |
$1K |
| 76830 |
Ultrasound, transvaginal |
24 |
24 |
$1K |
| 73630 |
|
116 |
115 |
$1K |
| 72110 |
|
60 |
60 |
$1K |
| 84439 |
|
141 |
135 |
$1K |
| 73610 |
|
51 |
47 |
$1K |
| 87807 |
|
63 |
61 |
$998.06 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
199 |
188 |
$974.22 |
| 85651 |
|
344 |
302 |
$923.24 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
29 |
28 |
$897.53 |
| 81001 |
|
361 |
338 |
$797.94 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
110 |
110 |
$765.14 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14 |
14 |
$748.27 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
51 |
48 |
$674.20 |
| 82607 |
|
59 |
56 |
$667.09 |
| 87081 |
|
110 |
110 |
$631.71 |
| 85027 |
|
51 |
50 |
$460.83 |
| 82746 |
|
43 |
42 |
$454.56 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$393.35 |
| 86618 |
|
13 |
13 |
$376.62 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
12 |
$364.30 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
94 |
92 |
$347.10 |
| 73030 |
|
14 |
14 |
$237.98 |
| 81025 |
|
44 |
44 |
$197.56 |
| 73130 |
|
14 |
14 |
$178.04 |
| 86140 |
|
59 |
55 |
$175.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,065 |
978 |
$144.89 |
| 83540 |
|
12 |
12 |
$123.99 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,050 |
893 |
$73.49 |
| 83550 |
|
12 |
12 |
$73.32 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$15.83 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
443 |
244 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
23 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$0.00 |